Unauthorized injectable peptide drugs seized and sold by Canada Peptide may pose serious health risks Canada.ca FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette Regulatory Alert: The Legal Status of BPC 157 in Compounding and Clinical Practice Holt Law The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype The FDA has issued warning letters to multiple companies marketing compounded Retatrutide, an investigational drug from Eli Lilly still in Phase II trials. While early studies have shown promising weight loss results, Retatrutide FDA Moves to Reevaluate Several Peptides American Med Spa Association